Grace Therapeutics, Inc.
GRCE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001444192
In the last 90 days, Grace Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.
Holders of 5% or more of GRCE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Grace Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 13G/A | 9.99%1.40M shares | 0.00 ppfrom 9.99% | May 15, 20252 filings | Aug 14, 2025 | SEC |
| ADAR1 Capital Management, LLC | 13G/A | 9.90%1.53M shares | −0.09 ppfrom 9.99% | May 15, 20252 filings | Nov 14, 2025 | SEC |
| Hirschman Orin | 13G/A | 9.90%1.32M shares | +4.80 ppfrom 5.10% | Jan 29, 20252 filings | May 8, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
6 Schedule 13D and 13G filings on Grace Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20257:44 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.90%1.53M shares | −0.09 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20254:43 PM ET | Nantahala Capital Management, LLCand 2 others | 13G/A | 9.99%1.40M shares | 0.00 ppfrom 9.99% | Jun 30, 2025 | SEC |
| May 15, 20257:33 PM ET | ADAR1 Capital Management, LLCand 2 others | 13G/A | 9.99%1.50M shares | – | Mar 31, 2025 | SEC |
| May 15, 20254:46 PM ET | Nantahala Capital Management, LLCand 2 others | 13G | 9.99%1.39M shares | New | Mar 31, 2025 | SEC |
| May 8, 20257:51 AM ET | Hirschman Orinand 1 other | 13G/A | 9.90%1.32M shares | +4.80 ppfrom 5.10% | Mar 31, 2025 | SEC |
| Jan 29, 20256:13 AM ET | Hirschman Orinand 1 other | 13G/A | 5.10%521.1K shares | – | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Grace Therapeutics, Inc. shares.
No Form 144 notices for Grace Therapeutics, Inc. are on file.